What this means
This is a clinical trial registration that is still recruiting people, so no results are posted yet. It tells us the study wants to see if combined tests might predict disability changes.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 1 site, including California
The science
- Registered title
- MS-ResearchBiomarkerS
- Trial ID
- NCT05204459 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Clinically Isolated Syndrome, Radiologically Isolated Syndrome, Neuromyelitis Optica Spectrum Disorders, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Neurologic Autoimmune Disease, Neurologic Disorder, Healthy Aging
- Sponsor
- Cedars-Sinai Medical Center
- Ages
- 18 Years to no maximum
- Dates
- First posted Jan 24, 2022 · updated Feb 6, 2024
Registry summary
This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to assess whether combining information from visual assessment, blood markers, as well as historical and ongoing longitudinal MRIs of the brain, orbit (the part of the skull where eyes are located), and/or spinal cord can predict changes in quantitative disability measures related to MSRD and neurological disease.
Sites (1)
- Cedars-Sinai Medical Center, Los Angeles, California, United States